CAJ | 학술논문

目的观察美托洛尔联合胺碘酮治疗快速心律失常的临床疗效.方法选取快速心律失常患者196例,按照数字随机表法将其分为对照组和观察组.每组98例.对照组患者采用胺碘酮治疗,观察组患者在对照组治疗基础上再予以美托洛尔治疗.比较两组患者的临床疗效.结果观察组患者治疗总有效率明显高于对照组患者,组间比较差异具有显著性(P<0.05),两组患者不良反应发生率无明显差异(P>0.05).结论美托洛尔联合胺碘酮治疗快速心律失常具有安全、疗效确切的优点,具有一定的临床价值.
목적관찰미탁락이연합알전동치료쾌속심률실상적림상료효.방법선취쾌속심률실상환자196례,안조수자수궤표법장기분위대조조화관찰조.매조98례.대조조환자채용알전동치료,관찰조환자재대조조치료기출상재여이미탁락이치료.비교량조환자적림상료효.결과관찰조환자치료총유효솔명현고우대조조환자,조간비교차이구유현저성(P<0.05),량조환자불량반응발생솔무명현차이(P>0.05).결론미탁락이연합알전동치료쾌속심률실상구유안전、료효학절적우점,구유일정적림상개치.
Objective To observe the clinical efficacy for Metoprolol and amiodarone in the treatment of tachyarrhythmia. Methods 196 cases of tachyarrhythmia patients were chosen as the research object. They were divided into the control group and the observation group in accordance with the digital random table method, and 98 cases in each group. The control group was taken with amiodarone, and the observation group was taken with metoprolol on the basis of the control group. The clinical effcacy of the two groups was compared. Results The total effciency in the observation group was signifcantly higher than the control group, the differences between groups were signifcant (P<0.05), the incidence of adverse reactions of the two groups of patients was without signifcant difference (P>0.05). Conclusion Metoprolol and amiodarone in the treatment of tachyarrhythmia has the advantages of safety and certain effcacy, it is of a certain clinical value.